Loading clinical trials...
Loading clinical trials...
The objective of the study was to compare the efficacy of Magnevist (SH L 451 A) at doses of 0.1 mmol/kg and 0.2 mmol/kg in contrast-enhanced 3D-Magnetic Resonance Angiography in three regions (abdomi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
NCT06782100 · Peripheral Vascular Diseases
NCT07322913 · Carotid Artery Diseases, Aortic Diseases, and more
NCT06656988 · Peripheral Vascular Diseases, Kidney Diseases
NCT06777901 · Peripheral Arterial Diseases
NCT04922762 · Peripheral Vascular Diseases
Hirosaki-shi, Aomori
Funai-gun, Kyoto
Hamamatsu, Shizuoka
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions